Information between 8th November 2024 - 8th December 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Division Votes |
|---|
|
12 Nov 2024 - House of Lords (Hereditary Peers) Bill - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 344 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 98 Noes - 375 |
|
12 Nov 2024 - House of Lords (Hereditary Peers) Bill - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 343 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 93 Noes - 355 |
|
12 Nov 2024 - House of Lords (Hereditary Peers) Bill - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 344 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 98 Noes - 376 |
|
12 Nov 2024 - House of Lords (Hereditary Peers) Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 340 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 435 Noes - 73 |
|
12 Nov 2024 - House of Lords (Hereditary Peers) Bill - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 342 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 41 Noes - 378 |
|
13 Nov 2024 - Exiting the European Union - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 338 Labour Aye votes vs 1 Labour No votes Tally: Ayes - 412 Noes - 16 |
|
19 Nov 2024 - Passenger Railway Services (Public Ownership) Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 324 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 350 Noes - 108 |
|
19 Nov 2024 - Passenger Railway Services (Public Ownership) Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 320 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 344 Noes - 172 |
|
27 Nov 2024 - Finance Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 319 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 332 Noes - 176 |
|
27 Nov 2024 - Finance Bill - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 320 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 112 Noes - 333 |
|
25 Nov 2024 - Non-Domestic Rating (Multipliers and Private Schools) Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 319 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 336 Noes - 175 |
|
25 Nov 2024 - Non-Domestic Rating (Multipliers and Private Schools) Bill - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 320 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 173 Noes - 335 |
|
26 Nov 2024 - Tobacco and Vapes Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 317 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 415 Noes - 47 |
|
29 Nov 2024 - Terminally Ill Adults (End of Life) Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 234 Labour Aye votes vs 147 Labour No votes Tally: Ayes - 330 Noes - 275 |
|
3 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 322 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 186 Noes - 330 |
|
3 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Chris Ward voted Aye - in line with the party majority and in line with the House One of 324 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 332 Noes - 189 |
|
4 Dec 2024 - Employer National Insurance Contributions - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 325 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 165 Noes - 334 |
|
4 Dec 2024 - Farming and Inheritance Tax - View Vote Context Chris Ward voted No - in line with the party majority and in line with the House One of 329 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 181 Noes - 339 |
| Speeches |
|---|
|
Chris Ward speeches from: Oral Answers to Questions
Chris Ward contributed 2 speeches (115 words) Monday 25th November 2024 - Commons Chamber Home Office |
| Written Answers |
|---|
|
Prostate Cancer: Drugs
Asked by: Chris Ward (Labour - Brighton Kemptown and Peacehaven) Tuesday 12th November 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what progress he has made on the development of a clinical policy relating to the use of abiraterone acetate as a first-line treatment for men with locally advanced high-risk prostate cancer; and when he expects to take a decision. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) NHS England has developed a policy proposal for abiraterone acetate and prednisolone to be used as a routine commissioning treatment option for high-risk, hormone sensitive, non-metastatic prostate cancer. In line with NHS England’s service development process, the policy proposal was considered by NHS England’s Clinical Priorities Advisory Group (CPAG) in May 2024. Work is currently underway to confirm decisions on new treatments, the position will be resolved as soon as possible, and NHS England will update clinicians and patient groups on the outcome. The CPAG's role is to make recommendations on the relative cost and benefit of different proposals, where they are outside the remit of the NICE, which in this case is because the treatment is an off-label use of abiraterone acetate and prednisolone. The CPAG assigns a priority level to different policies which may be funded through available discretionary funding. |